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Abstract  
 
Hepatitis C virus (HCV) release is linked to the formation of lipid droplet (LD) clusters in the 
perinuclear area of infected cells, induced by the core protein. We used electron microscopy 
(EM) to monitor and compare the number and size of LD in cells producing the mature and 
immature forms of the HCV core protein, and 3D EM to reconstruct whole cells producing 
the mature core protein. Only the mature protein coated the LD and induced their clustering 
and emergence from endoplasmic reticulum membranes enriched in this protein. We found no 
particular association between LD clusters and the centrosome in reconstructed cells. The LD 
clustering induced by the mature core protein was associated with an increase in LD synthesis 
potentially due, at least in part, to the ability of this protein to coat the LD. These observations 
provide useful information for further studies of the mechanisms involved in HCV-induced 
steatosis. 
 
Keywords: HCV • lipid droplet • steatosis • electron microscopy • 3D reconstruction 
 
Abbreviations: HCV, hepatitis C virus; ER, endoplasmic reticulum; SPP, signal peptide 
peptidase; SFV, Semliki forest virus; EM, electron microscopy; !-Gal, !-galactosidase; WT, 
wild-type. 
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Introduction 
 
Hepatitis C virus (HCV), a member of the Flaviridae family, is a major cause of chronic liver 
disease, infecting an estimated 170 million people worldwide [1]. The spectrum of severity of 
the liver disease associated with HCV is broad and the rate of progression to advanced 
fibrosis and cirrhosis is highly variable. This rate seems to depend on many host-related 
cofactors, such as age at infection, sex, alcohol consumption, being overweight and co-
infections with hepatitis B virus or human immunodeficiency virus [2].  Retrospective studies 
have shown that advanced fibrosis is associated with the presence and severity of liver 
steatosis, characterised by the deposition of triglycerides in the liver [3,4]. There is therefore a 
considerable interest in dissecting the mechanisms of steatosis in HCV infection, particularly 
in relation to other metabolic disturbances. Steatosis is frequent in hepatitis C patients. 
Indeed, before the advent of serological testing, the presence of fatty acids in the liver was 
widely considered to be suggestive of a diagnosis of non-A, non-B hepatitis [5].  Steatosis 
depends on both viral and host factors. Virus-induced steatosis is mostly reported in patients 
infected with HCV genotype 3, in whom fat accumulation is correlated with HCV replication 
in the serum [3] and liver [6] and is resolved by successful antiviral treatment [7, 8], strongly 
suggesting that specific viral products are involved in the fat deposition. By contrast, most 
cases of mild steatosis in patients infected with genotypes other than 3 seem to have a 
metabolic pathogenesis, with being overweight identified as the most significant clinical 
correlate [3]. This type of steatosis tends to be associated with a lower likelihood of 
virological response to antiviral drugs [9] and frequently persists in patients responding to 
antiviral treatment, consistent with HCV playing no major role in its pathogenesis [8, 9]. Both 
types of steatosis (viral and metabolic) may co-exist in at least some chronic hepatitis C 
patients, although steatosis is more likely to be predominantly viral in origin in patients 
infected with genotype 3 viruses and predominantly metabolic in patients infected with 
viruses of other genotypes. 
 The HCV genome consists of a positive-sense, single-stranded RNA molecule of 9.6 
kilobases [10]. Translation of the genome generates a polyprotein of approximately 3000 
amino acids, which is cleaved by a combination of viral and cellular proteases to produce the 
mature structural and non-structural proteins. The structural protein involved in nucleocapsid 
assembly - the core protein – has been shown to induce steatosis in two lines of transgenic 
mice [11, 12]. HCV core protein production is associated with multiple changes in lipogenic 
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gene expression [13-16] and lipogenic proteins activity [17, 18], and also has effects on 
mitochondrial oxidative function [19-21].  In vitro studies on various cell lines rapidly 
established that the HCV core protein was located at the  surface of lipid droplets acting as 
intracellular storage sites for triglycerides and cholesterol esters [22-25]. Moreover, HCV 
core has been shown to be present on lipid droplets in liver biopsy specimens from infected 
chimpanzees [23]. These observations raise the intriguing possibility that this particular 
localization is somehow linked to liver steatosis [26]. Recent fundamental research studies 
made possible by the isolation of a virus strain (JFH-1 for Japanese Fulminant Hepatitis clone 
1) producing infectious HCV from tissue culture cells have demonstrated that the initiation of 
nascent virions assembly and production takes place at lipid droplets [27]. Indeed, attachment 
of the HCV core protein to lipid droplets is linked to the release of infectious progeny virions 
from infected cells. This release is accompanied by the redistribution of lipid droplets within 
infected cells, with the clustering of these lipid droplets in the perinuclear area [28]. This 
redistribution requires only the mature HCV core protein, generated by cleavage with two 
cellular enzymes: signal peptidase and signal peptide peptidase (SPP). The first of these 
enzymes releases the core protein from the polyprotein targeted to the endoplasmic reticulum 
(ER) membrane, generating an immature form of the core protein that contains the signal 
peptide [29]. Complete processing of the protein requires further proteolysis by SPP, which 
cleaves within the signal peptide. This second cleavage event is essential for the trafficking of 
the core protein to the lipid droplet [29]. The redistribution of lipid droplets induced by the 
mature HCV core protein depends on the microtubule network and is thought to increase the 
likelihood of interaction between the core protein and the site of HCV RNA replication within 
a network of membranes in the perinuclear area [28]. Thus, the association of the HCV core 
protein with lipid droplets seems to play a central role in both HCV pathogenesis and 
morphogenesis, suggesting that virus-induced steatosis may be essential for the viral life 
cycle.  
 We have previously established a cellular model based on HCV core protein 
production in which lipid droplets accumulate and cluster in the perinuclear area of the 
transfected cells [30]. Using this model, together with a new method for monitoring the 
number and size of lipid droplets in transfected cells, we demonstrated that the production of 
a core protein bearing residues specific to HCV genotype 3 was associated with a higher 
amount of lipid droplets than the production of a wild-type (WT) core protein of genotype 1 
[30]. Thus, our cellular model seems to mimic, in vitro, virus-induced steatosis and its 
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genotype-specific influence. In this study, we used this model to compare the amount of 
intracellular lipid droplets in cells producing immature and mature HCV core proteins. We 
also analysed the clustering of lipid droplets induced by the mature HCV core protein, by 3D 
electron microscopy, and considered the implication of these observations for the potential 
mechanisms underlying HCV-induced steatosis. 
 
Materials and Methods 
 
Insertion of the HCV core sequences into Semilki forest virus (SFV) vectors and site-directed 
mutagenesis to generate an HCV core mutant not cleaved by SPP 
 
The HCV core 1a construct was obtained from our previously described [31]. genotype 1a 
cDNA clone (Dj6.4; Genbank accession number AF529293) containing the C-E1-E2 coding 
sequence. The WT core construct was amplified by PCR, using PfuTurbo DNA polymerase 
(Stratagene, La Jolla, CA) with primers flanked by BamH1 sites, as previously reported [32]. 
Site-directed mutagenesis within the C-terminal core signal sequence was performed with 
antisense primers leading to (i) the generation of a triple mutant VLV180-3-4 (Fig. 1a) and (ii) 
the insertion of a stop codon at the 3’ end of the core protein-coding region [33]. This 
particular mutant has been shown to be resistant to SPP cleavage [33]. The sequences 
encoding the WT and mutated core proteins were inserted separately into the polylinker 
BamH1 site of the expression vector pSFV1 (Life Technologies, Rockville, MD). DNA 
sequencing was used to check that the original sequence was conserved in both constructs and 
that the VLV180-3-4 mutations were correctly introduced in the mutant. 
 
Cell culture and transfection with RNA  
 
Baby hamster kidney cells (BHK-21) were cultured and electroporated with recombinant SFV 
RNA encoding the HCV WT or VLV180-3-4 core protein, as previously described [30, 33]. 
Briefly, cells were cultured at 37°C in Glasgow Minimal Essential Medium (GMEM) 
supplemented with 5% foetal calf serum and 8 % tryptose phosphate. For recombinant RNA 
synthesis, the various pSFV1 constructs were linearised by digestion at the SpeI restriction 
site downstream from the 3’ non-coding region of the SFV replicon. Transcription was then 
carried out in vitro with SP6 RNA polymerase, making use of the SP6 promoter located 
upstream from the 5’ extremity of the SFV replicon, as recommended by the manufacturer 
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(Invitrogen). As a control, we synthesised a recombinant RNA encoding !-galactosidase (!-
Gal). For transfection, 10 x 106 cells were mixed with 5 µg of recombinant SFV RNA and 
electroporated by a single pulse at 350 V, 750 mF (Easyject One, Eurogentec). Cells were 
cultured for 16 h following electroporation, as our previous studies have shown that the major 
morphological events associated with HCV structural protein production occur during this 
period in this system [30, 33]. All experiments other than confocal microscopy studies of the 
subcellular distribution of core proteins were conducted with BHK-21 cells. For these 
confocal microscopy studies, we transfected the human hepatocellular carcinoma cell line 
FLC4 under similar conditions. The lower efficiency of the SFV vectors in these cells resulted 
in the production of smaller amounts of protein than in BHK-21 cells, allowing a more precise 
analysis of the subcellular distribution of proteins and an analysis of co-localisation with 
lipids [30, 33]. 
 
Western blotting 
 
Transfected BHK-21 cells were treated with a lysis buffer containing 1% NP-40, 140 mM 
NaCl, 100 mM Tris-HCl pH8, 1% sodium deoxycholate, 0.1% sodium dodecyl sulphate, 1 
mM phenylmethylsulfonyl fluoride, 2 !g/ml aprotinin, and 2 !g/ml leupeptin. Samples were 
then separated by SDS-PAGE in 15 % polyacrylamide gels and the resulting bands were 
transferred to a polyvinylidene difluoride membrane. The membrane was blocked by 
incubation in 0.05 % (vol/vol) Tween 20 in phosphate buffered saline (PBS) supplemented 
with 2 % (wt/vol) skimmed milk powder (PBS-T). Membranes were incubated with the 
human monoclonal anti-HCV core B12F8 antibody (gift of Dr M. Mondelli) diluted 1:500 in 
PBS-T, washed and incubated with a horseradish peroxidase-conjugated anti-human antibody 
diluted 1:5000 in PBS-T. Antibody binding was detected by enhanced chemiluminescence 
(ECL Plus; Amersham Bioscience). 
 
Confocal microscopy  
 
Transfected FLC4 cells were cultured on glass coverslips for 16 h and were then fixed by 
incubation for 30 minutes in 4% paraformaldehyde in PBS at room temperature. The reaction 
was quenched and the cells were permeabilised by incubation for 30 minutes in 0.05% 
saponin-0.2% bovine serum albumin (BSA) in PBS. HCV core proteins were detected by 
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incubating the cells for 30 minutes with the mouse monoclonal anti-HCV core antibody C7-
50 (Abcam, Cambridge, MA), diluted 1:100 in permeabilisation buffer. The cells were then 
washed and incubated with a secondary anti-mouse antibody coupled to Alexa Fluor 488 
(Molecular Probes, Eugene, OR), diluted 1:1000 in permeabilisation buffer. For lipid staining, 
the cells were treated with Nile Red (Sigma Aldrich), diluted 1:1000 (from a 1 mg/ml stock 
solution in acetone) in permeabilisation buffer, during incubation with the secondary 
antibody. Confocal microscopy was performed with an Olympus Fluoview 500 instrument.  
 
Electron microscopy and immuno-electron microscopy 
 
For standard electron microscopy (EM), transfected BHK-21 cells were fixed by incubation 
for 48 h in 4% paraformaldehyde and 1% glutaraldehyde in 0.1 M phosphate buffer (pH 7.2) 
and postfixed by incubation for 1 h with 2% osmium tetroxide (Electron Microscopy Science, 
Hatfield, PA). They were dehydrated in a graded series of ethanol solutions, cleared in 
propylene oxide, and embedded in Epon resin (Sigma), which was allowed to polymerise for 
48 h at 60°C. Ultrathin sections were cut, stained with 5 % uranyl acetate, 5 % lead citrate, 
and placed on EM grids coated with collodion. The sections were then observed with a Jeol 
1230 transmission electron microscope (Tokyo, Japan) connected to a Gatan digital camera 
driven by Digital Micrograph software (Gatan, Pleasanton, CA) for image acquisition and 
analysis. For immuno-EM, transfected BHK-21 cells were fixed by incubation in a solution 
containing 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2) for 16 h. The cells were 
collected by centrifugation and the cell pellet was then dehydrated in a graded series of 
ethanol solutions at –20°C, using an automatic freezing substitution system (AFS, Leica), and 
embedded in London resin white (Electron Microscopy Science). The resin was allowed to 
polymerise at –25°C, under UV light, for 72 h. Ultrathin sections were cut and blocked by 
incubation with 1% fraction V bovine serum albumin (BSA, Sigma) in PBS. They were then 
incubated with anti-HCV core C7-50 monoclonal antibody diluted 1:50 in PBS supplemented 
with 1% BSA, washed and incubated with goat anti-mouse antibodies conjugated to 15 nm 
gold particles (British Biocell International, Cardiff, UK) diluted 1:40 in PBS supplemented 
with 0.1% BSA. We used conjugated goat secondary antibodies without prior incubation with 
primary antibody to check that the reaction was specific. Ultrathin sections were stained and 
observed as described above.  
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Lipid droplet quantification and statistical analysis 
 
We used our recently established method for morphometric analysis of  the lipid droplets 
encountered in cells [30]. Briefly, for each construct (!-Gal, WT core, VLV180-3-4 core 
mutant), the number and diameter (in µm) of lipid droplets were determined on the computer 
screen for 100 consecutive EM (standard) sections of the transfected BHK-21 cells. Lipid 
droplet diameter was converted into an area in µm2. By summing these areas, we were able to 
determine the cumulative lipid droplet area, in µm2, for each cell section. Lipid droplet areas 
in 100 consecutive EM sections of the transfected cells seemed to follow mixed distributions. 
Indeed, the probability of observing a null area (discrete component of the distribution) was 
non-null, whereas a probability density function existed for all non-zero values of cumulative 
areas (continuous component of the distribution). We therefore categorised the variable before 
carrying out statistical tests. Based on Sturges’ rule, we defined seven classes of cumulative 
lipid droplet area (0 µm2; 0-0.25 µm2; 0.25-0.5 µm2 ; 0.5-1 µm2; 1-1.5 µm2;  1.5-2 µm2; 2-4 
µm2), thereby defining an ordinal variable. Constructs were compared by chi-squared test for 
trend taking into account the ordinal nature of the newly created variables. We also 
considered the proportion of cell sections with null area which were compared by a chi-
squared test. Data were analysed with SAS 9.1 software. 
 
Triglyceride quantification 
 
Ten millions of BHK-21 cells transfected with recombinant SFV RNA encoding the HCV 
WT, VLV180-3-4 core protein or "-galactosidase were collected in 1mL of PBS. Total lipids 
extraction was performed using a method adapted from Folch et al [34]. Briefly 3 mL of a 2:1 
chloroform-methanol (v/v) mixture and 1 mL water were added to 1 mL of cell suspension. 
After homogenization and centrifugation the resulting mixture separated into two phases. The 
lower phase containing total lipids was collected, then evaporated, and lipids were dissolved 
in isopropanol. Triglyceride concentration was then measured by enzymatic reaction using the 
colorimetric kit TG PAP 150 (BioMérieux, Marcy l’Etoile, France). Data were displayed with 
the "-galactosidase as control (test/control ratio of the optic density values). 
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Three-dimensional (3D) reconstruction analysis of whole cells producing the WT HCV core 
protein 
 
We have recently described the use of serial EM sections for the 3D reconstruction of large 
cellular microdomains in cells producing the HCV core protein [35]. This previous study 
demonstrated that the budding of the HCV-like particles formed by self-assembly of the HCV 
core protein was initiated mostly at ER membranes closely associated with lipid droplets [34]. 
In this study, we used a similar approach to reconstruct several whole BHK-21 cells 
producing the WT HCV core protein. Briefly, we resized our Epon blocks to cut a ribbon of 
serial ultrathin sections (75 nm thick) of transfected cells. EM grids were stained as described 
above, and electron micrographs were collected with a digital camera for the same region of 
cells in each of the series of sections. Photoshop software was used to align image stacks for 
these serial EM sections. As the electron beam distorts ultrathin sections slightly, it was 
necessary to align the images based on the position of specific structures of interest. Contours 
were carefully drawn with IMOD software [36] through the same specific cellular structures 
on different serial sections. These structures included the plasma membrane, nuclear 
envelope, lipid droplets and centrosome. The contours from a stack of serial sections were 
then arranged into objects with IMOD. Using the IMODmesh feature of IMOD, we then 
joined the contours of each object to form a 3D model. Nine cells were analysed thoroughly 
to determine the subcellular distribution of their lipid droplets. A lipid droplet cluster was 
defined as at least three droplets grouped together, with the individual droplets of the cluster 
separated by less than the mean diameter of a lipid droplet (i.e. 0.5 µm). A lipid droplet 
cluster was considered to be closely associated with a centrosome if at least one lipid droplet 
from the cluster was less than 1.5 µm from the nearest centriole. 
 
Results 
 
Expression and processing of HCV WT core and VLV180-3-4 core mutant proteins 
 
Sixteen hours after transfection with the constructs encoding HCV core proteins or the !-gal 
control, the cells were harvested and lysed for western-blot analysis (Fig. 1b). Consistent with 
our previous findings [30-33], the WT core protein encoded by the Dj6.4 sequence appeared 
to be fully cleaved by SPP, leading to the detection of a p21 protein, whereas the VLV180-3-4 
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core mutant remained uncleaved, resulting in the detection of a p23 form of the core protein. 
We used Image J software for gel analysis to quantify the WT and mutant core proteins in the 
scanned blot and found that these two proteins were present in similar amounts.  
 
Colocalisation of HCV core proteins with lipid droplets 
 
Nile red labelling in cells transfected with the !-gal construct showed that lipid droplets were 
evenly distributed throughout the cytoplasm (Fig. 1c). Transfection with the WT core 
construct induced the clustering of large lipid droplets in the perinuclear area, as previously 
reported for our model [30, 33] and for other in vitro cellular models [28]. The surface of 
these droplets was strongly stained for HCV core protein, as previously described in these 
models [28, 30, 33]. Transfection with the VLV180-3-4 core mutant construct did not induce 
lipid droplet clustering and this mutant core protein displayed only a weak association with 
lipids, which were evenly distributed throughout the cytoplasm, as previously described [33]. 
Similar results were obtained when the experiment was repeated and for analyses of large 
numbers of cells (only one cell is shown for each construct in Fig. 1c, to show the 
colocalisation of HCV core proteins and lipid droplets as clearly as possible).  
 
Electron microscopy and immuno-electron microscopy  
 
Standard electron microscopy showed that the ultrastructural changes observed in cells 
transfected with recombinant SFV vectors encoding the WT core protein were consistent with 
our previous findings [30, 33], with the clustering of large lipid droplets in the perinuclear 
area (Fig. 2, top). These lipid droplet clusters were systematically surrounded by convoluted 
ER membranes rich in HCV-like particles budding towards the lumen of this convoluted ER 
compartment, as previously described (fig. 2) [35]. Transfection with !-Gal RNA had no 
effect on ER morphology, with linear ER membranes evenly distributed throughout the 
cytoplasm (not shown). Immuno-electron microscopy on freeze-substituted cells producing 
the WT core protein showed that the surface of the clustered lipid droplets and their 
surrounding ER membranes stained strongly positive for HCV core protein (Fig. 2, bottom). 
Standard electron microscopy in cells transfected with the recombinant SFV RNA encoding 
the VLV180-3-4 core mutant revealed multiple layers of dense ER membranes, as previously 
described [33] (Fig. 2, top). It has been suggested that this particular mutant, which is not 
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processed by SPP and thus remains anchored in the ER membrane by its transmembrane 
sequence signal, induces these multi-layered ER membranes by protein-protein interaction 
[33]. This hypothesis was recently confirmed by another group [37]. Immuno-electron 
microscopy on freeze-substituted cells producing this mutant showed that these multi-layered 
ER membranes were strongly positive for HCV core protein (Fig. 2, bottom).  
 
Lipid droplet quantification  
 
We determined the cumulative area covered by lipid droplets for 100 consecutive cell 
sections, for each construct, studied in random order (Fig. 3). The cumulative area of the lipid 
droplets was higher for both core proteins than for the control protein !-gal (p<0.0001 for the 
WT core protein ; p=0.0029 for the VLV180-3-4 core mutant). This cumulative area was greater 
for the WT core protein than for the VLV180-3-4 mutant core protein, although this difference 
was of low significance (p=0.0634). However, the proportion of cell sections with null areas 
(thick lines in 0) was lower with the  WT core protein than with the VLV 180/3/4 core mutant 
protein (respectively 35% versus 56%, p=0.003). 
 
Triglyceride quantification 
 
We measured the total amount of triglycerides in cells transfected with the various 
constructions, using a commercially available colorimetric assay. Triglyceride accumulation 
in cell producing the VLV180-3-4 core mutant or the WT core protein was about 1.5-fold and 
2.0-fold with respect to the control !-galactosidase protein, respectively (Fig. 4). 
 
3D reconstruction analysis of whole cells producing the WT HCV core protein 
 
Nine cells producing the WT core protein and containing at least one lipid droplet cluster 
were fully reconstructed in 3D with our method based on serial EM sections (between 150 to 
180 sections for a typical cell). We considered a lipid droplet cluster to have formed when 
three of more lipid droplets were found in close proximity (less than the mean lipid droplet 
diameter - 0.5 µm – apart). We observed one to four lipid droplet clusters per cell in these 
nine cells and analysed 20 lipid droplet clusters in total. A lipid droplet cluster was considered 
to be associated with a centrosome when at least one of the lipid droplets of the cluster was 
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found to be located less than 1.5 µm from the nearest centriole. Only four out of these 20 lipid 
droplet clusters observed were associated with a centrosome. In the cases in which only one 
lipid droplet cluster per cell was observed, the lipid droplet cluster concerned was never 
associated with the centrosome. Figure 5 illustrates a typical cell with a single large lipid 
droplet cluster, in which the centrosome is opposite the lipid droplet cluster within the 
cytoplasm (see also the QuickTime movie of the 3D reconstruction of this cell, provided 
online at SpringerLink), which illustrate the spatial distribution of these different organelles 
within the cell). 
 
Discussion 
 
A recent study assessing the spatial dispersion of lipid droplets through the cytoplasm by 
confocal microscopy demonstrated that these organelles group together in clusters in the 
perinuclear area of HCV-infected cells [28]. Disruption of the microtubule network or the 
microinjection of dynein antibodies prevent the formation of these clusters, which are thought 
to occur specifically around the centrosome. The authors of this previous study interpreted 
these results as indicating a global redistribution of the pre-existing lipid droplets following 
HCV infection, through the trafficking of these organelles along the microtubule network and 
towards the centrosome. This phenomenon was observed in the hepatoma cell line Huh7 
infected with the complete virus (the JFH-1 strain), but also in Huh7 cells producing only the 
mature HCV core protein of various genotypes [28]. An immature core protein (i.e. not 
cleaved by SPP) did not induce these specific clusters in the Huh7 cells and the lipid droplets 
therefore remained dispersed through the cytoplasm. This previous study was based on a 
system of core protein production from an SFV vector, resulting in the rapid induction of 
these lipid droplet clusters in 16h, rather than three days required in cells infected with the 
complete virion [28]. To investigate this phenomenon further, we used here SFV vectors to 
produce the mature and immature core proteins in the BHK-21 cell line. This cell line was 
chosen for the high percentage of transfected cells (near 100%) reached after electroporation, 
allowing a better analysis of the changes induced by the core proteins in the lipid droplets 
amount. Moreover, this cell line has been previously shown to accumulate triglycerides in 
cytoplasmic lipid droplets [38]. We used different EM approaches such as immuno-EM, 3D 
reconstructions and EM for lipid droplet quantification. EM has been shown to be a more 
appropriate method than light microscopy for quantifying the lipid droplets within cells [35], 
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and 3D EM reconstructions gave a more precise subcellular localisation of centrosomes and 
lipid droplets.  
Our morphometric analysis of lipid droplets in cells transfected with the various 
constructs clearly shows that HCV core protein production is associated with a larger 
cumulative area being covered by lipid droplets. This greater area was observed for both the 
mature (WT) and immature (uncleaved mutant) forms of the HCV core protein. This was also 
supported by the quantification of the triglycerides in the transfected cells, showing an 
increase in triglyceride synthesis in cells producing the WT and mutant core proteins, as 
compared to the !-galactosidase control protein. Thus, the various mechanisms potentially 
involved in core-induced steatosis, including lipogenic gene expression [13-16], the 
modulation of lipogenic protein functions [17, 18], and effects on mitochondrial oxidative 
function [19-21] may also potentially be induced by an uncleaved HCV core protein. Both 
mature and immature core proteins have been shown to be involved in upregulation of the 
fatty acid synthetase (FAS) gene promoter [39]. Our results suggest that the change in the 
distribution of lipid droplets observed in cells producing the mature core protein is not due 
simply to the redistribution of the pre-existing droplets. This redistribution seems instead to 
be associated with the synthesis of new lipid droplets, due to the direct lipogenic effects of the 
HCV core protein. Further support for this interpretation is also provided by our 3D 
reconstructions of whole cells producing the mature core protein. These 3D reconstructions 
show that clusters of lipid droplets do not specifically arise close to the centrosome. The 
precise localisation of the lipid droplets clusters and centrosomes possible with this EM 
approach and the use of serial ultrathin sections is not consistent with the formation of these 
clusters by the simple migration of pre-existing droplets toward the centrosome. Again, our 
3D EM analysis is more consistent with the de novo synthesis of lipid droplets at the site of 
cluster formation.  
It remains unclear how triglycerides and other neutral lipids are packaged into 
cytosolic droplets. Several hypotheses have been proposed concerning nascent lipid droplet 
formation [39-42]. According to the most widely supported of these hypotheses, lipids 
accumulate between the two leaflets of the ER membrane, gradually taking on a globular 
shape and then being pinched off from the ER to become independent lipid droplets 
surrounded by a single, ER-derived, monolayer membrane [40-43]. However, neither nascent 
lipid droplets nor lipid deposition in the ER membrane has ever been visualised, due to 
technical constraints and the extremely rapid nature of this phenomenon, which takes place 
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over the course of a few minutes [44]. Nevertheless, it has been suggested that the proteins of 
the PAT family (for perilipin-adipophilin-Tip47), which coat the lipid droplets, may be 
involved in this mechanism [45]. All PAT proteins have similar sequences and can bind to the 
surface of intracellular lipid droplets, either constitutively or in response to metabolic stimuli, 
such as an increased in lipid flux into or out of lipid droplets [46]. Each PAT protein has a 
unique tissue distribution, subcellular localisation, and lipid-binding properties, consistent 
with each of these proteins playing a unique role in triglyceride management [47]. These 
proteins are exchangeable at the surface of the lipid droplets in various conditions, and these 
exchanges regulate the storage of lipids within the cell [45, 46]. It has been suggested that 
PAT family proteins not only coat the droplets but actually order triglyceride packaging, by 
managing the interface between the droplet and the cytosol and contributing to membrane 
curvature and the pinching off of the lipid droplet [45]. It has been shown that the mature 
HCV core displaces adipophilin from the surface of the lipid droplet [28]. Thus, in cells 
producing the mature HCV core protein, lipid droplets may emerge from the ER membranes 
in which the core protein is synthesised, due to a specific role of the mature core protein in 
lipid droplet morphogenesis. This may also explain how the HCV core protein replaces 
adipophilin at the surface of the lipid droplet. Immuno-EM observations, such as that shown 
for the mature/WT core protein in Figure 2 support this model. Indeed, the lipid droplets seem 
to emerge from ER membranes rich in HCV core protein. Similar findings were obtained if 
the experiment was repeated and for large numbers of cells. It is indeed difficult to believe 
that lipid droplets dispersed throughout the cytoplasm would move specifically towards these 
areas with a core-rich ER membrane. It seems more likely that these lipid droplets surrounded 
by the HCV core protein bud from these specific ER domains enriched in core protein. So, 
what makes this phenomenon possible ? Recent studies have suggested that lipid droplets are 
extremely dynamic organelles that may undergo repeated cycles of fusion and fission with the 
ER membrane, thereby accumulating or regressing within the confines of ER membranes [40, 
41, 43, 47]. Lipids may then diffuse laterally in the ER towards the nascent lipid droplets [43]. 
This movement of lipid droplet may make it possible to deliver lipids to various membrane 
organelles in the cell for lipid exchange [48]. The fusion and fission of lipid droplets is 
probably favoured by the mobility of these organelles along the microtubule network [41, 48]. 
This could concern the radial, centrosome-attached microtubules but also the whole network 
of non-centrosomal microtubules. Thus, this mobility would account for the prevention of 
lipid droplet clustering in response to HCV core protein following disruption of the 
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microtubule network or the microinjection of antibodies against motor proteins such as dynein 
[28]. 
Cells producing the WT/mature core protein contained larger amounts of lipid droplets 
than cell producing the immature/uncleaved mutant core protein. The reason for this 
difference is unknown, but it may be due to the ability of the mature core protein to localise at 
the surface of the lipid droplets, contributing to the morphogenesis of these organelles. 
Indeed, the overexpression of various members of the PAT family, such as adipophilin and 
perilipin, is associated with an expansion of the pool of lipid droplets within the cell [49-51].  
The HCV mature core protein present at the surface of the lipid droplet may exert an 
additional effect through specific lipid interaction, increasing the number and/or size of lipid 
droplets within the cell, or by inducing the fusion of many small and invisible lipid droplets 
forming large, more visible droplets. Alternatively, the mature core protein may induce a 
higher amount of triglyceride synthesis, as suggested by our intracellular triglyceride 
quantification. However, all these mechanisms may act together to induce the accumulation of 
lipid droplets in clusters seen in cells producing the WT HCV core protein, the fusion of 
nascent or existing lipid droplets to form larger droplets remaining a matter of debate [52].  
In conclusion, we have shown that the clustering of lipid droplets induced by the HCV 
core protein does not result from a simple redistribution of  pre-existing organelles. Instead, 
the HCV core protein seems to induce the de novo synthesis of lipid droplets in the 
perinuclear area of the cell. These results provide some insight into how HCV “hijacks” these 
organelles for its own life cycle. They also shed light on the mechanisms of lipid droplet 
morphogenesis and dynamic, which have remained poorly understood. Furthermore, our 
study demonstrates that the formation of these clusters by the HCV core protein is associated 
with a major increase in the cumulative area covered by lipid droplets. This increase may be 
due to the intrinsic properties of the core protein (mature or immature) and its interaction with 
various molecules involved in the lipid metabolism, but may also be due in part to the ability 
of the mature core protein to coat the nascent lipid droplets. These results should help to guide 
future studies of the mechanisms involved in the pathogenesis of HCV-induced liver steatosis. 
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Figure legends 
 
Fig. 1 Analysis of HCV core protein production and core-E1 signal peptide processing. (a) : 
Signal sequences of the two HCV core proteins used in this study : the wild-type (WT) 
protein and the VLV180-3-4 mutant. The transmembrane region of the signal sequence at the 
core-E1 junction is boxed. (b): Production of the WT and VLV180-3-4 mutant core proteins in 
BHK-21 cells, and analysis of HCV core protein processing by SDS-PAGE and western 
blotting. The WT core protein was fully cleaved by SPP, appearing at 21 kDa, whereas the 
VLV180-3-4 mutant core protein remained uncleaved, resulting in detection of the p23 kDa 
form of the core protein. Cells producing !-gal were used as a control and an anti-actin 
antibody was used to normalise the Western blott. (c): Immunofluorescence of WT and 
VLV180-3-4 core proteins, combined with Nile red staining of lipid droplets in FLC4 cells. 
Lipid droplets were evenly distributed throughout the cytoplasm of cells producing !-Gal 
(negative control). Significant clusters of lipid droplets co-localised with core protein were 
observed in the perinuclear area of cells transfected with the WT core construct, but not in 
cells producing the VLV180-3-4 mutant core. 
 
Fig. 2 Electron micrographs of ultrathin sections of BHK-21 cells producing the WT core or 
VLV180-3-4 core mutant protein studied by regular EM (upper image) or freeze substitution and 
immunogold labeling with a monoclonal anti-HCV core (lower image). Cells producing the 
WT core protein contained convoluted ER membranes surrounding clusters of lipid droplets 
(LD). These convoluted membranes surrounding the droplets and the surface of the droplets 
themselves stained strongly for the HCV core by immunogold labelling. Cells producing the 
VLV180-3-4 core mutant contained abundant electron-dense, multi-layered structures formed by 
the interaction of multiple ER membranes (see also the inset corresponding to an enlargement 
of the area indicated by the arrow). These multi-layered ER membranes were strongly 
positive for the HCV core protein on immunogold labelling. No gold labelling was detected at 
the surface of the lipid droplets in these cells. All these structures were specific to the HCV 
core protein, as none of these modifications or immunogold labelling was detected in cells 
producing !-gal (data not shown). Scale bars correspond to 0.5 µm in all micrographs. 
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Fig. 3 Quantification of the cumulative area covered by lipid droplets in sections of BHK-21 
cells producing the WT core protein, the VLV180-3-4 core mutant, or the !-galactosidase 
control protein. The cumulative area covered by lipid droplets per cell section (in µm2) was 
determined on 100 consecutive cell sections for each protein. The cumulative lipid droplet 
area was categorised into seven classes: 0 µm2; 0-0.25 µm2; 0.25-0.5 µm2 ; 0.5-1 µm2; 1-1.5 
µm2;  1.5-2 µm2; 2-4 µm2. The probability distributions were mixed distributions. The thick 
line in 0 indicates the frequency of null areas, whereas non-null areas are presented as 
histograms. The chi-squared test associated with the comparison of the WT core with the 
VLV180-3-4 core mutant or !-galactosidase yielded p values of 0.0634 and <0.0001, 
respectively. The chi-squared test associated with the comparison of VLV180-3-4 core mutant 
with !-galactosidase yielded a p value of 0.0029.  
 
Fig. 4 Triglyceride quantification in BHK-21 cells producing the WT core protein, the 
VLV180-3-4 core mutant, or the !-galactosidase control protein, using a commercially available 
assay (Biomérieux). Data are displayed with the "-galactosidase as control (test/control ratio 
of the optic density values), and are means + standard deviations of four independent 
quantifications. 
 
Fig. 5 Three-dimensional reconstruction of a BHK-21 cell producing the WT core protein. (a) 
: typical single ultrathin section of this cell, showing its centrosome (arrow and enlargement 
in the inset) distant from the cluster of lipid droplets (LD). Bars 2 µm. (b) : Four different 
views of the reconstruction of this cell obtained with IMOD software and a total of 145 serial 
ultrathin (60-70 nm thick) EM sections, showing the plasma membrane (light green), the 
nucleus (purple), the centrosome (light purple and arrow) and the lipid droplets (yellow). The 
cluster of lipid droplets is located in a cellular domain opposite to the centrosome (arrows). A 
QuickTime movie of this 3D reconstruction is also provided as supplemental material online 
at SpringerLink. 
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